Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Voyager Therapeutics (VYGR) Other Gross PP&E Adjustments (2016 - 2025)

Voyager Therapeutics (VYGR) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 72.47% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.3 million through Dec 2025, up 72.47% year-over-year, with the annual reading at -$2.3 million for FY2025, 72.47% up from the prior year.
  • Other Gross PP&E Adjustments hit -$2.3 million in Q4 2025 for Voyager Therapeutics, up from -$30.1 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $14.9 million in Q4 2022 to a low of -$39.8 million in Q1 2024.
  • Historically, Other Gross PP&E Adjustments has averaged -$20.6 million across 5 years, with a median of -$23.4 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 538.52% in 2022 and later plummeted 165.33% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at -$3.4 million in 2021, then soared by 538.52% to $14.9 million in 2022, then decreased by 13.94% to $12.9 million in 2023, then tumbled by 165.33% to -$8.4 million in 2024, then soared by 72.47% to -$2.3 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for VYGR at -$2.3 million in Q4 2025, -$30.1 million in Q3 2025, and -$31.7 million in Q2 2025.